Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05400109
Title Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors James Michael Martin
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242 United States Details
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland Ohio 44106 United States Details
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field